Clopidogrel for the secondary prevention of stroke
Authors:
- 10 May 2005
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 6 (5) , 755-764
Abstract
Patients suffering a transient ischaemic attack (TIA) or ischaemic stroke (IS) have a high risk of recurrence. The inhibition of platelet function is effective in the reduction of secondary vascula...Keywords
This publication has 33 references indexed in Scilit:
- Early risk of recurrence by subtype of ischemic stroke in population-based incidence studiesNeurology, 2004
- P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteriesJournal of Clinical Investigation, 2003
- Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data BankStroke, 2001
- Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteersBritish Journal of Clinical Pharmacology, 2001
- P2Y12, a New Platelet ADP Receptor, Target of ClopidogrelBiochemical and Biophysical Research Communications, 2001
- Role of P2Y1 purinoceptor in ADP‐induced platelet activationFEBS Letters, 1998
- Aspirin in Ischemic Cerebrovascular DiseaseStroke, 1996
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Vascular Event Rates in Patients With Atherosclerotic Cerebrovascular DiseaseArchives of Neurology, 1992
- Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992